Activation of plasmacytoid dendritic cells

Immunology and Cell Biology

Volumn 83, Issue 5, 2005, Pages 571-577

  Fuchsberger, Martina ^a   Hochrein, Hubertus ^b   O'Keeffe, Meredith ^b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Bavarian Nordic GmbH   (Germany)

Author keywords

Autoimmune disease; NF B; Pattern recognition receptor (PRR); Plasmacytoid dendritic cell (pDC); Toll like receptor (TLR)

Indexed keywords

ANTIVIRUS AGENT; IMIDAZOQUINOLINE DERIVATIVE; IMIQUIMOD; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

AUTOIMMUNE DISEASE; CELL ACTIVATION; CONTACT DERMATITIS; DENDRITIC CELL; DENGUE; DERMATOMYOSITIS; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX VIRUS 1; HUMAN; INNATE IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; PSORIASIS; REVIEW; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; DENDRITIC CELLS; HUMANS; LIGANDS; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); HEPATITIS C VIRUS; HUMAN HERPESVIRUS 1; MAMMALIA;

EID: 29144471826     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2005.01392.x     Document Type: Review

References (82)

1. Fitzgerald-Bocarsly P. Human natural interferon-alpha producing cells. Pharmacol. Ther. 1993; 60: 39-62.
2. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 1997; 185: 1101-111.
3. Eckert F, Schmid U. Identification of plasmacytoid T cells in lymphoid hyperplasia of the skin. Arch. Dermatol. 1989; 125: 1518-24.
4. Asselin-Paturel C, Boonstra A, Dalod M et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2001; 2: 1144-50.
5. Bjorck P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 2001; 98: 3520-26.
6. Nakano H, Yanagita M, Gunn MD. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 2001; 194: 1171-8.
7. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005; 23: 275-306.
8. Hochrein H, O'Keeffe M, Wagner H. Human and mouse plasmacytoid dendritic cells. Hum. Immunol 2002; 63: 1103-110.
9. Krug A, Towarowski A, Britsch S et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 2001; 31: 3026-37.
10. Proietto AI, O'Keeffe M, Gartlan K et al. Differential production of inflammatory chemokines by murine dendritic cell subsets. Immunobiology 2004; 209: 163-72.
11. O'Keeffe M, Hochrein H, Vremec D et al. Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8 (+) dendritic cells only after microbial stimulus. J. Exp. Med. 2002; 196: 1307-319.
12. Janeway CA, Medzhitov R. Innate immune recognition 1. Annu. Rev. Immunol. 2002; 20: 197-216.
13. Boonstra A, Asselin-Paturel C, Gilliet M et al. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J. Exp. Med. 2003; 197: 101-109.
14. Diebold SS, Montoya M, Unger H et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003; 424: 324-8.
15. Edwards AD, Diebold SS, Slack EM et al. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 2003; 33: 827-33.
16. Ito T, Amakawa R, Kaisho T et al. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med. 2002; 195: 1507-512.
17. Kadowaki N, Ho S, Antonenko S et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001; 194: 863-9.
18. Naik SH, Proietto AI, Wilson NS et al. Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 2005; 174: 6592-7.
19. Verthelyi D, Zeuner RA. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol. 2003; 24: 519-22.
20. Belz GT, Vremec D, Febbraio M et al. CD36 is differentially expressed by CD8+ splenic dendritic cells but is not required for cross-presentation in vivo. J. Immunol. 2002; 168: 6066-70.
21. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 2003; 85: 85-95.
22. Bauer S, Kirschning CJ, Hacker H et al. Human TER9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl Acad. Sci. USA 2001; 98: 9237-42.
23. Hochrein H, Wagner H. Of men, mice and pigs: looking at their plasmacytoid dendritic cells. Immunology 2004; 112: 26-7.
24. Yasuda K, Yu P, Kirschning CJ et al. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J. Immunol. 2005; 174: 6129-36.
25. Lee J, Chuang TH, Redecke V et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor. Proc. Natl Acad. Sci. USA 2003; 100: 6646-51.
26. Jurk M, Heil F, Vollmer J et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 2002; 3: 499.
27. Hemmi H, Kaisho T, Takeuchi O et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002; 3: 196-200.
28. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303: 1529-31.
29. Heil F, Hemmi H, Hochrein H et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526-9.
30. Hornung V, Guenthner-Biller M, Bourquin C et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 2005; 11: 263-70.
31. Omatsu Y, Iyoda T, Kimura Y et al. Development of murine plasmacytoid dendritic cells defined by increased expression of an inhibitory NK receptor, Ly49Q. J. Immunol. 2005; 174: 6657-62.
32. Lock K, Zhang J, Lu J, Lee SH, Crocker PR. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells. Immunobiology 2004; 209: 199-207.
33. Bave U, Magnusson M, Eloranta ML, Perers A, Alm GV, Ronnblom L. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J. Immunol. 2003; 171: 3296-302.
34. Green DS, Lum T, Green JA. IgG-derived Fc down-regulates virus-induced plasmacytoid dendritic cell (pDC) IFNalpha production. Cytokine 2004; 26: 209-216.
35. Means TK, Latz E, Hayashi F, Murali MR, Golenbock DT, Luster AD. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 2005; 115: 407-417.
36. Novak N, Allam JP, Hagemann T et al. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J. Allergy Clin. Immunol. 2004; 114: 364-70.
37. LeibundGut-Landmann S, Waldburger JM, Reis e Sousa C, Acha-Orbea H, Reith W. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nat. Immunol. 2004; 5: 899-908.
38. Martinon F, Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 2005; in press.
39. Yang GX, Lian ZX, Kikuchi K et al. CD4- plasmacytoid dendritic cells (pDCs) migrate in lymph nodes by CpG inoculation and represent a potent functional subset of pDCs. J. Immunol. 2005; 174: 3197-203.
40. Kamogawa-Schifter Y, Ohkawa J, Namiki S, Arai N, Arai K, Liu Y. Ly49Q defines 2 pDC subsets in mice. Blood 2005; 105: 2787-92.
41. Kawai T, Sato S, Ishii KJ et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 2004; 5: 1061-8.
42. Honda K, Yanai H, Mizutani T et al. Role of a transductional- transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl Acad. Sci. USA 2004; 101: 15 416-21.
43. Uematsu S, Sato S, Yamamoto M et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR) 7- and TLR9-mediated interferon-{alpha} induction. J. Exp. Med. 2005; 201: 915-23.
44. Schoenemeyer A, Barnes BJ, Mancl ME et al. The Interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J. Biol. Chem. 2005; 280: 17 005-17 012.
45. Mancl ME, Hu G, Sangster-Guity N et al. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J. Biol. Chem. 2005; 280: 21 078-90.
46. Honda K, Ohba Y, Yanai H et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005; 434: 1035-40.
47. Kerkmann M, Costa LT, Richter C et al. Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells. J. Biol. Chem. 2005; 280: 8086-93.
48. Hemmi H, Kaisho T, Takeda K, Akira S. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 2003; 170: 3059-64.
49. Martin P, Del Hoyo GM, Anjuere F et al. Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 2002; 100: 383-90.
50. Latz E, Schoenemeyer A, Visintin A et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 2004; 5: 190-98.
51. Fuchs A, Cella M, Kondo T, Colonna M. Paradoxical inhibition of human natural interferon-producing cells by the activating receptor NKp44. Blood 2005; in press.
52. Dzionek A, Sohma Y, Nagafune J et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 2001; 194: 1823-34.
53. Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004; 25: 280-88.
54. O'Keeffe M, Grumont RJ, Hochrein H et al. Distinct roles for the NF-κB1 and c-Rel transcription factors in the differentiation and survival of plasmacytoid and conventional dendritic cells activated by TLR-9 signals. Blood 2005; in press.
55. Barnes BJ, Kellum MJ, Field AE, Pitha PM. Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol. Cell. Biol. 2002; 22: 5721-40.
56. Hochrein H, Schlatter B, O'Keeffe M et al. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc. Natl Acad. Sci. USA 2004; 101: 11 416-21.
57. Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004; 103: 1433-7.
58. Ronnblom L, Alm GV. Systemic lupus erythematosus and the type I interferon system. Arthritis Res. Ther. 2003; 5: 68-75.
59. Bave U, Nordmark G, Lovgren T et al. Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum. 2005; 52: 1185-95.
60. Nestle FO, Conrad C, Tun-Kyi A et al. Plasmacytoid pre-dendritic cells initiate psoriasis through interferon-{alpha} production. J. Exp. Med. 2005; 202: 135-43.
61. Gilliet M, Conrad C, Geiges M et al. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch. Dermatol. 2004; 140: 1490-95.
62. Wollenberg A, Wagner M, Gunther S et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J. Invest. Dermatol. 2002; 119: 1096-102.
63. Bangert C, Friedl J, Stary G, Stingl G, Kopp T. Immunopathologic features of allergic contact dermatitis in humans: participation of plasmacytoid dendritic cells in the pathogenesis of the disease? J. Invest. Dermatol 2003; 121: 1409-418.
64. Cavanagh LL, Boyce A, Smith L et al. Rheumatoid arthritis synovium contains plasmacytoid dendritic cells. Arthritis Res. Ther. 2005; 7: R230-40.
65. Lande R, Giacomini E, Serafini B et al. Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J. Immunol. 2004; 173: 2815-24.
66. Van Krinks CH, Matyszak MK, Gaston JS. Characterization of plasmacytoid dendritic cells in inflammatory arthritis synovial fluid. Rheumatology (Oxford) 2004; 43: 453-60.
67. Azzoni L, Rutstein RM, Chehimi J, Farabaugh MA, Nowmos A, Montaner LJ. Dendritic and natural killer cell subsets associated with stable or declining CD4+ cell counts in treated HIV-1-infected children. J. Infect. Dis. 2005; 191: 1451-9.
68. Donaghy H, Stebbing J, Patterson S. Antigen presentation and the role of dendritic cells in HIV. Curr. Opin. Infect. Dis. 2004; 17: 1-6.
69. Pichyangkul S, Endy TP, Kalayanarooj S et al. A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity. J. Immunol. 2003; 171: 5571-8.
70. Anthony DD, Yonkers NL, Post AB et al. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J. Immunol. 2004; 172: 4907-916.
71. Duan XZ, Wang M, Li HW, Zhuang H, Xu D, Wang FS. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J. Clin. Immunol. 2004; 24: 637-46.
72. Goutagny N, Vieux C, Decullier E et al. Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection. J. Infect. Dis. 2004; 189: 1646-55.
73. Murakami H, Akbar SM, Matsui H, Horiike N, Onji M. Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin. Exp. Immunol. 2004; 137: 559-65.
74. Tsubouchi E, Akbar SM, Horiike N, Onji M. Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection. J. Gastroenterol. 2004; 39: 754-62.
75. Ulsenheimer A, Gerlach JT, Jung MC et al. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology 2005; 41: 643-51.
76. van der Molen RG, Sprengers D, Binda RS et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004; 40: 738-46.
77. De Wit D, Olislagers V, Goriely S et al. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004; 103: 1030-32.
78. Dakic A, Shao QX, D'Amico A et al. Development of the dendritic cell system during mouse ontogeny. J. Immunol. 2004; 172: 1018-27.
79. Vollstedt S, O'Keeffe M, Odermatt B et al. Treatment of neonatal mice with Flt3 ligand leads to changes in dendritic cell subpopulations associated with enhanced IL-12 and IFN-alpha production. Eur. J. Immunol. 2004; 34: 1849-60.
80. Vollstedt S, Franchini M, Hefti HP et al. Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections. J. Exp. Med. 2003; 197: 575-84.
81. Fugier-Vivier IJ, Rezzoug F, Huang Y et al. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J. Exp. Med. 2005; 201: 373-83.
82. de Heer HJ, Hammad H, Soullie T et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 2004; 200: 89-98.